Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis

Kosaku Nanki, Shinta Mizuno, Katsuyoshi Matsuoka, Keiko Ono, Shinya Sugimoto, Hiroki Kiyohara, Mari Arai, Moeko Nakashima, Kozue Takeshita, Keiichiro Saigusa, Mitsutoshi Senoh, Tadashi Fukuda, Makoto Naganuma, Haru Kato, Wataru Suda, Masahira Hattori, Takanori Kanai

    Research output: Contribution to journalArticle

    1 Citation (Scopus)

    Abstract

    Fecal microbiota transplantation (FMT) has been reported as a safe and effective therapy in patients with refractory and recurrent Clostridium difficile infection (CDI). FMT has also been reported as a promising therapy in patients with ulcerative colitis (UC). Both, CDI and UC, are believed to be caused by dysbiosis, such as altered compositions or decreased diversity of the intestinal microbiota. This report describes a patient with UC in remission with a second recurrent episode of CDI, who was treated with FMT. A single FMT performed via colonoscopy completely resolved the patient's diarrhea and eradicated C. difficile bacteriologically without any severe complications. Molecular biological analysis of the patient's fecal microbiota showed that FMT could dramatically change the altered composition of intestinal microbiota and restore its diversity. Despite the restoration of the intestinal microbiota, FMT could not prevent a relapse of UC in this patient. However, it improved the intestinal symptoms of CDI and could prevent further recurrences of CDI.

    Original languageEnglish
    Pages (from-to)142-146
    Number of pages5
    JournalIntestinal Research
    Volume16
    Issue number1
    DOIs
    Publication statusPublished - 2018 Jan 1

    Fingerprint

    Clostridium Infections
    Clostridium difficile
    Ulcerative Colitis
    Dysbiosis
    Recurrence
    Microbiota
    Colonoscopy
    Fecal Microbiota Transplantation
    Diarrhea
    Therapeutics
    Gastrointestinal Microbiome

    Keywords

    • Clostridium difficile
    • Colitis
    • Fecal microbiota transplantation
    • Ulcerative

    ASJC Scopus subject areas

    • Gastroenterology

    Cite this

    Nanki, K., Mizuno, S., Matsuoka, K., Ono, K., Sugimoto, S., Kiyohara, H., ... Kanai, T. (2018). Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis. Intestinal Research, 16(1), 142-146. https://doi.org/10.5217/ir.2018.16.1.142

    Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis. / Nanki, Kosaku; Mizuno, Shinta; Matsuoka, Katsuyoshi; Ono, Keiko; Sugimoto, Shinya; Kiyohara, Hiroki; Arai, Mari; Nakashima, Moeko; Takeshita, Kozue; Saigusa, Keiichiro; Senoh, Mitsutoshi; Fukuda, Tadashi; Naganuma, Makoto; Kato, Haru; Suda, Wataru; Hattori, Masahira; Kanai, Takanori.

    In: Intestinal Research, Vol. 16, No. 1, 01.01.2018, p. 142-146.

    Research output: Contribution to journalArticle

    Nanki, K, Mizuno, S, Matsuoka, K, Ono, K, Sugimoto, S, Kiyohara, H, Arai, M, Nakashima, M, Takeshita, K, Saigusa, K, Senoh, M, Fukuda, T, Naganuma, M, Kato, H, Suda, W, Hattori, M & Kanai, T 2018, 'Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis' Intestinal Research, vol. 16, no. 1, pp. 142-146. https://doi.org/10.5217/ir.2018.16.1.142
    Nanki, Kosaku ; Mizuno, Shinta ; Matsuoka, Katsuyoshi ; Ono, Keiko ; Sugimoto, Shinya ; Kiyohara, Hiroki ; Arai, Mari ; Nakashima, Moeko ; Takeshita, Kozue ; Saigusa, Keiichiro ; Senoh, Mitsutoshi ; Fukuda, Tadashi ; Naganuma, Makoto ; Kato, Haru ; Suda, Wataru ; Hattori, Masahira ; Kanai, Takanori. / Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis. In: Intestinal Research. 2018 ; Vol. 16, No. 1. pp. 142-146.
    @article{526fdd4653044b1aad343429cdaea397,
    title = "Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis",
    abstract = "Fecal microbiota transplantation (FMT) has been reported as a safe and effective therapy in patients with refractory and recurrent Clostridium difficile infection (CDI). FMT has also been reported as a promising therapy in patients with ulcerative colitis (UC). Both, CDI and UC, are believed to be caused by dysbiosis, such as altered compositions or decreased diversity of the intestinal microbiota. This report describes a patient with UC in remission with a second recurrent episode of CDI, who was treated with FMT. A single FMT performed via colonoscopy completely resolved the patient's diarrhea and eradicated C. difficile bacteriologically without any severe complications. Molecular biological analysis of the patient's fecal microbiota showed that FMT could dramatically change the altered composition of intestinal microbiota and restore its diversity. Despite the restoration of the intestinal microbiota, FMT could not prevent a relapse of UC in this patient. However, it improved the intestinal symptoms of CDI and could prevent further recurrences of CDI.",
    keywords = "Clostridium difficile, Colitis, Fecal microbiota transplantation, Ulcerative",
    author = "Kosaku Nanki and Shinta Mizuno and Katsuyoshi Matsuoka and Keiko Ono and Shinya Sugimoto and Hiroki Kiyohara and Mari Arai and Moeko Nakashima and Kozue Takeshita and Keiichiro Saigusa and Mitsutoshi Senoh and Tadashi Fukuda and Makoto Naganuma and Haru Kato and Wataru Suda and Masahira Hattori and Takanori Kanai",
    year = "2018",
    month = "1",
    day = "1",
    doi = "10.5217/ir.2018.16.1.142",
    language = "English",
    volume = "16",
    pages = "142--146",
    journal = "Intestinal Research",
    issn = "1598-9100",
    publisher = "Korean Association for the Study of Intestinal Diseases",
    number = "1",

    }

    TY - JOUR

    T1 - Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis

    AU - Nanki, Kosaku

    AU - Mizuno, Shinta

    AU - Matsuoka, Katsuyoshi

    AU - Ono, Keiko

    AU - Sugimoto, Shinya

    AU - Kiyohara, Hiroki

    AU - Arai, Mari

    AU - Nakashima, Moeko

    AU - Takeshita, Kozue

    AU - Saigusa, Keiichiro

    AU - Senoh, Mitsutoshi

    AU - Fukuda, Tadashi

    AU - Naganuma, Makoto

    AU - Kato, Haru

    AU - Suda, Wataru

    AU - Hattori, Masahira

    AU - Kanai, Takanori

    PY - 2018/1/1

    Y1 - 2018/1/1

    N2 - Fecal microbiota transplantation (FMT) has been reported as a safe and effective therapy in patients with refractory and recurrent Clostridium difficile infection (CDI). FMT has also been reported as a promising therapy in patients with ulcerative colitis (UC). Both, CDI and UC, are believed to be caused by dysbiosis, such as altered compositions or decreased diversity of the intestinal microbiota. This report describes a patient with UC in remission with a second recurrent episode of CDI, who was treated with FMT. A single FMT performed via colonoscopy completely resolved the patient's diarrhea and eradicated C. difficile bacteriologically without any severe complications. Molecular biological analysis of the patient's fecal microbiota showed that FMT could dramatically change the altered composition of intestinal microbiota and restore its diversity. Despite the restoration of the intestinal microbiota, FMT could not prevent a relapse of UC in this patient. However, it improved the intestinal symptoms of CDI and could prevent further recurrences of CDI.

    AB - Fecal microbiota transplantation (FMT) has been reported as a safe and effective therapy in patients with refractory and recurrent Clostridium difficile infection (CDI). FMT has also been reported as a promising therapy in patients with ulcerative colitis (UC). Both, CDI and UC, are believed to be caused by dysbiosis, such as altered compositions or decreased diversity of the intestinal microbiota. This report describes a patient with UC in remission with a second recurrent episode of CDI, who was treated with FMT. A single FMT performed via colonoscopy completely resolved the patient's diarrhea and eradicated C. difficile bacteriologically without any severe complications. Molecular biological analysis of the patient's fecal microbiota showed that FMT could dramatically change the altered composition of intestinal microbiota and restore its diversity. Despite the restoration of the intestinal microbiota, FMT could not prevent a relapse of UC in this patient. However, it improved the intestinal symptoms of CDI and could prevent further recurrences of CDI.

    KW - Clostridium difficile

    KW - Colitis

    KW - Fecal microbiota transplantation

    KW - Ulcerative

    UR - http://www.scopus.com/inward/record.url?scp=85040679999&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85040679999&partnerID=8YFLogxK

    U2 - 10.5217/ir.2018.16.1.142

    DO - 10.5217/ir.2018.16.1.142

    M3 - Article

    VL - 16

    SP - 142

    EP - 146

    JO - Intestinal Research

    JF - Intestinal Research

    SN - 1598-9100

    IS - 1

    ER -